Dysregulated Myogenesis in Rhabdomyosarcoma
- 31 October 2017
- book chapter
- Published by Elsevier
- Vol. 126, 285-297
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cellsMolecular Cancer, 2013
- Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cellsOncogene, 2012
- Inhibition of the Notch-Hey1 Axis Blocks Embryonal Rhabdomyosarcoma TumorigenesisClinical Cancer Research, 2011
- Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivoCell Death & Differentiation, 2011
- Childhood RhabdomyosarcomaJournal of Dental Research, 2011
- Genome-wide MyoD Binding in Skeletal Muscle Cells: A Potential for Broad Cellular ReprogrammingDevelopmental Cell, 2010
- The Notch Effector Hey1 Associates with Myogenic Target Genes to Repress MyogenesisJournal of Biological Chemistry, 2010
- Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtypeBritish Journal of Cancer, 2009
- Credentialing a Preclinical Mouse Model of Alveolar RhabdomyosarcomaCancer Research, 2009
- Epigenetic mechanisms in mammalsCellular and Molecular Life Sciences, 2008